Latest PROF reports update at 2024-05-11: 2023 ∙ 2022 ∙ 2021

Profound Medical Corp. PROF

$ 8.52 13.6%

Profound Medical Corp. Balance Sheet 2011-2024 | PROF

Annual Balance Sheet Profound Medical Corp.

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-	-	-7.36 M	-18.7 M	-5.96 M	-10.6 M	-3.37 M	1.31 M	-	-	-
Long Term Debt	-	-	-	-	6.72 M	10.6 M	444 K	2.8 M	4.01 M	1.95 M	-	-	-
Long Term Debt Current	259 K	239 K	250 K	312 K	199 K	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	2.44 M	9.69 M	12 M	3.01 M	2.91 M	4.29 M	-	-	-	-
Total Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	12.7 M	12.4 M	6.16 M	7.25 M	-	-	13.7 M	6.59 M	5.21 M	103 K	-	-	-
Deferred Revenue	-	-	-	358 K	655 K	313 K	241 K	193 K	-	-	-	-	-
Retained Earnings	-	-	-	-130 M	-131 M	-111 M	-90.3 M	-53.2 M	-39.7 M	-453 K	-	-	-
Total Assets	43.9 M	64.4 M	86.8 M	105 M	-	-	27.9 M	17.6 M	15.3 M	1.47 M	-	-	-
Cash and Cash Equivalents	26.2 M	46.5 M	67.2 M	83.9 M	14.8 M	-	-	-	-	-	-	-	-
Book Value	31.2 M	52 M	80.6 M	97.4 M	-	-	14.1 M	11 M	10.1 M	1.37 M	-	-	-
Total Shareholders Equity	-	-	-	97.4 M	14.4 M	-	-	-	-	-	-	-	-

All numbers in USD currency

Quarterly Balance Sheet Profound Medical Corp.

	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	-	-	-	-	1.13 M	-	-	-	1.36 M	-	-	-	1.64 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	-	-	-	-	6.16 M	-	-	-	7.25 M	-	-	-	15.7 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-	-	-	-	-161 M	-	-	-	-130 M	-	-	-	-108 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	-	-	-	-	86.8 M	-	-	-	105 M	-	-	-	30.1 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	-	-	-	-	67.2 M	-	-	-	83.9 M	-	-	-	14.8 M	-	-	-	22.5 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	-	-	-	-	80.6 M	-	-	-	97.4 M	-	-	-	14.4 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	-	-	-	-	80.6 M	-	-	-	97.4 M	-	-	-	14.4 M	-	-	-	19.6 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency